Jonsson Comprehensive Cancer Center: Pancreatic Neoplasms trials

The registry lists 11 Pancreatic Neoplasms studies with Jonsson Comprehensive Cancer Center as lead sponsor. 1 are open to participants now and 0 have results posted.

Early Phase 1 2Phase 1 5Phase 2 1No phase 3(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• AB801 in Combination With Chemotherapy and Immunotherapy for the Treatment of Patients With Borderline Resectable, Locally Advanced or Metastatic Cholangiocarcinoma or Pancreatic CancerRecruitingNCT07619313Phase 1
• Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic CancersActive, not recruitingNCT07118176Phase 1
• Malnutrition Screening and Dietary Intervention to Improve Nutrition Outcomes in Patients With Unresectable Pancreatic CancerActive, not recruitingNCT06090916Not applicable
• Red Blood Cell Transfusion Thresholds for Improved Quality of Life for Patients Undergoing a Pancreatectomy for Pancreatic CancerTerminatedNCT05841706Early Phase 1
• Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer TissuesActive, not recruitingNCT04147494Early Phase 1
• Compassionate Single Subject Use of FG-3019 (FibroGen) in Locally Advanced, Unresectable Pancreatic CancerWithdrawnNCT02851381Not applicable
• Nutrition Support to Improve Outcomes in Patients With Unresectable Pancreatic CancerTerminatedNCT02681601Not applicable
• Phase I Study to evaluate124I-A11 PSCA Minibody in Patients With Metastatic Prostate, Bladder and Pancreatic CancerCompletedNCT02092948Phase 1
• Genistein in Treating Patients With Pancreatic Cancer That Can Be Removed by SurgeryWithdrawnNCT00882765Phase 2
• SU006668 in Treating Patients With Advanced Solid TumorsStatus unknownNCT00024063Phase 1
• Monoclonal Antibody ABX-EGF in Treating Patients With Renal (Kidney), Prostate, Pancreatic, Non-Small Cell Lung, Colon or Rectal, Esophageal, or Gastroesophageal Junction CancerCompletedNCT00004879Phase 1